NewsResearch
Understanding Cancer Survival Statistics in the News
Cancer statistics appear in headlines all the time. Here's what they measure, why trends matter more than single numbers, and why they don't predict any one person's outcome.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
The number in the headline is about someone else
Cancer statistics are built to describe populations. A headline that says survival is 70 percent is reporting what happened to a large group of people diagnosed years ago. It is not a forecast for the person reading it.
NCI states this directly. Statistical trends are usually not directly applicable to individual patients. They exist so governments, policymakers, clinicians, and researchers can see the shape of the problem and measure whether efforts against it are working.
What "5-year relative survival" actually measures
This is the figure that appears most often, and it is widely misread.
SEER defines relative survival as an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It deliberately excludes the risk of dying from other causes. A 78-year-old who dies of heart disease three years after a cancer diagnosis is not counted against the cancer figure.
Three things follow from that.
It is not a cure rate. Surviving five years does not mean the cancer is gone.
It is not a countdown either. The five-year mark is a convention for comparing groups, not a biological threshold.
And it looks backward. SEER's current figures cover people diagnosed between 2016 and 2022. Their treatment was the treatment available then. Anyone diagnosed today is being treated with more.
SEER itself puts the limit plainly: because these statistics are based on large groups, they cannot be used to predict exactly what will happen to an individual patient. No two patients are alike, and treatment and responses to treatment vary greatly.
The current numbers, for scale
For 2026 SEER carries 2,114,850 new cancer cases in the United States and 626,140 deaths, neither of them SEER's own count: both are American Cancer Society projections. Five-year relative survival across all cancer types was 70.5 percent for cases from 2016 to 2022.
The rate of new cases was 450.7 per 100,000 people per year. The death rate was 143.2 per 100,000. Both are age-adjusted, which matters more than it sounds.
About 39.2 percent of people will be diagnosed with some cancer during their lifetime. In 2023 there were an estimated 18,640,213 people living with a cancer diagnosis in the United States. NCI projects the number of survivors will reach 26 million by 2040.
Why "more cancer" can mean better detection
Here is the trap NCI warns about, and it catches a lot of reporting.
Incidence is the rate of new diagnoses. It can rise for two very different reasons.
It can rise because more people are actually getting the disease, perhaps from more exposure to a risk factor. If that is what is happening, deaths from that cancer should rise too.
Or it can rise because a new test is finding cancers that would never have caused a problem in someone's lifetime. NCI calls this overdiagnosis. In that case incidence climbs and death rates do not move at all.
The two patterns look identical in a headline about "rising cases." They are opposite stories.
NCI's conclusion is that the best single indicator of progress is a change in age-adjusted mortality rates. Comparing mortality against incidence adds more: if deaths fall faster than diagnoses, or fall while diagnoses rise, that points to better treatment.
Why rates get age-adjusted
Cancer is largely a disease of aging, and populations age at different speeds.
If one country's population is older than another's, it will have more cancer regardless of anything else. The same is true when comparing a country against its own past.
Age adjustment recalculates rates as if every group had the same age structure. It is what makes the comparison mean something. NCI notes that the US population is aging, which is one reason case counts keep climbing even as death rates fall.
What the trend actually shows
The overall US cancer death rate has been falling since the early 1990s.
The Annual Report to the Nation on the Status of Cancer released in April 2025 gives the recent pace. Death rates fell 1.7 percent per year among men from 2018 to 2022, 1.3 percent per year among women over the same period, and 1.5 percent per year among children aged 0 to 14 from 2001 to 2022.
NCI is careful to add that rates for a few cancers have not changed or have increased, and that smoking has fallen while obesity has risen. Progress is real and uneven. Our page on cancer statistics goes through the main measures.
Where the data comes from
SEER stands for Surveillance, Epidemiology, and End Results. It is NCI's program of population-based cancer registries, and it covers roughly 48 percent of the US population.
That is a sample, not a census, and it is a deliberately representative one. The Annual Report to the Nation is written jointly by NCI, CDC, the American Cancer Society, and others.
That matters when reading a headline. A figure from a registry covering half a country carries different weight than one from a single hospital.
Reading a statistic about your own situation
A general survival figure lumps together every stage, age, subtype, and treatment. Almost all the information a person actually wants is in the parts that get averaged away.
Stage is usually the largest single factor, and stage-specific figures are published for most cancers. Subtype often matters as much. So do age, other health conditions, and what treatment is available now rather than in 2016.
That is the useful reframe. A headline number tells you about a disease. Your own team can tell you which slice of that number your situation sits in. Our page on cancer diagnosis covers the tests that determine those details.
What these numbers do not mean
They do not predict an individual outcome, and no reputable source claims otherwise.
They do not describe current treatment. Survival statistics necessarily lag by years, because someone has to survive five years before they can be counted.
And a change in a number is not automatically a change in reality. A new screening program, a change in coding, or a shift in who gets tested can move incidence without a single extra person getting sick. That is why mortality, age-adjusted and tracked over time, is the number worth watching.
Sources
- NCI, Cancer Statistics — https://www.cancer.gov/about-cancer/understanding/statistics
- SEER Cancer Stat Facts, Cancer of Any Site — https://seer.cancer.gov/statfacts/html/all.html
- SEER, Cancer Stat Facts — https://seer.cancer.gov/statfacts/
- American Cancer Society, Cancer Facts & Statistics — https://www.cancer.org/research/cancer-facts-statistics.html
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Cancer statistics. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.